JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB5813

Anti-PKC iota (phospho T555 + T563) antibody

Be the first to review this product! Submit a review

|

(23 Publications)

Rabbit Polyclonal PKC iota phospho T555 + T563 antibody. Suitable for Flow Cyt, WB and reacts with Mouse, Human samples. Cited in 23 publications. Immunogen corresponding to Synthetic Peptide within Human PRKCI phospho T555 + T563.

View Alternative Names

DXS1179E, PRKCI, Protein kinase C iota type, Atypical protein kinase C-lambda/iota, nPKC-iota, PRKC-lambda/iota, aPKC-lambda/iota

1 Images
Western blot - Anti-PKC iota (phospho T555 + T563) antibody (AB5813)
  • WB

Unknown

Western blot - Anti-PKC iota (phospho T555 + T563) antibody (AB5813)

Peptide Competition and Phosphatase Treatment : Lysates prepared from Jurkat cells stimulated with PMA were resolved by SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either left untreated (1-4) or treated with lambda phosphatase (5), blocked with a 5% low-fat milk-TBST buffer for one hour at room temperature, and incubated with ab5813 antibody for two hours at room temperature in a 3% low-fat milk-TBST buffer, following prior incubation with : no peptide (1), the non-phosphopeptide corresponding to the immunogen (2), a generic phosphothreonine-containing peptide (3), or, the phosphopeptide immunogen (4). After washing, membranes were incubated with goat F(ab’)2 anti-rabbit IgG HRP conjugate and bands were detected using the Pierce SuperSignalTM method. The data show that the phosphopeptide corresponding to PKC iota [pT555] blocks the antibody signal. The peptide corresponding to PKC zeta [pT560] blocks the antibody signal and the pepti

All lanes:

Western blot - Anti-PKC iota (phospho T555 + T563) antibody (ab5813)

Predicted band size: 68 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

Flow Cyt, WB

applications

Immunogen

Synthetic Peptide within Human PRKCI phospho T555 + T563. The exact immunogen used to generate this antibody is proprietary information.

P41743

Specificity

This antibody reacts with PKC lambda immunoprecipitates, indicating cross-reactivity for PKC lambda [pT563]. PKC zeta [pT560] (83% homologous) has been shown to cross-react by peptide competition. Peptide competition also suggests that this antibody may partially cross-react with PKC beta 1 [pS642] (58% homologous) and PKC nu [pT655] (42% homologous).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated PKC iota. The final product is generated by affinity chromatography using a PKC iota-derived peptide that is phosphorylated at threonine 555.
Storage buffer
pH: 7.3 Preservative: 0.05% Sodium azide Constituents: PBS, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Protein Kinase C (PKC) iota also known by its gene symbol PRKCI is an atypical member of the PKC family. It has a molecular mass of approximately 74 kDa. PKC iota does not respond to calcium and is insensitive to diacylglycerol and phorbol esters which differentiates it from other classical PKC family members. The protein initiates cell survival and proliferation pathways and is primarily expressed in brain heart liver and skeletal muscle tissues indicating its extensive role across various biological functions.
Biological function summary

PKC iota acts as an important player in regulating cell polarity and protecting cells from stress-induced apoptosis. It forms part of the Par6-Par3-PKC iota complex which is important for maintaining cell polarity and directional migration. This complex is essential for neural tube closure during embryonic development and in establishing cell polarity across diverse cell types. PKC iota also contributes to the regulation of microtubule organization reinforcing its vital role in maintaining cellular architecture.

Pathways

PKC iota is important in the NF-kB signaling pathway and the PI3K/AKT pathway. In the NF-kB pathway PKC iota activates IkB kinase leading to NF-kB transcriptional activity which promotes cell survival. In the PI3K/AKT pathway PKC iota contributes to cell growth and survival working closely with AKT proteins. These pathways highlight its involvement in processes like proliferation survival and cellular response to external stimuli.

PKC iota has a significant connection to cancer and neurological disorders. Its overexpression has been observed in several cancers such as lung and prostate cancer where it is often associated with poor prognosis. PKC iota’s role in the maintenance of cell polarity and survival links it to malignant cell behavior. Additionally in neurological disorders like Alzheimer’s disease alterations in PKC iota activity have been related to synaptic dysfunctions. Connections to proteins such as AKT and NF-kB in these conditions highlight its potential as a therapeutic target.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid beta protein-induced apoptosis by interrupting cell death process at a very early step. In glioblastoma cells, may function downstream of phosphatidylinositol 3-kinase (PI(3)K) and PDPK1 in the promotion of cell survival by phosphorylating and inhibiting the pro-apoptotic factor BAD. Can form a protein complex in non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and regulate ECT2 oncogenic activity by phosphorylation, which in turn promotes transformed growth and invasion. In response to nerve growth factor (NGF), acts downstream of SRC to phosphorylate and activate IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal cell survival. Functions in the organization of the apical domain in epithelial cells by phosphorylating EZR. This step is crucial for activation and normal distribution of EZR at the early stages of intestinal epithelial cell differentiation. Forms a protein complex with LLGL1 and PARD6B independently of PARD3 to regulate epithelial cell polarity. Plays a role in microtubule dynamics in the early secretory pathway through interaction with RAB2A and GAPDH and recruitment to vesicular tubular clusters (VTCs). In human coronary artery endothelial cells (HCAEC), is activated by saturated fatty acids and mediates lipid-induced apoptosis. Involved in early synaptic long term potentiation phase in CA1 hippocampal cells and short term memory formation (By similarity).
See full target information PRKCI phospho T555 + T563

Publications (23)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:10541 PubMed39627191

2024

Cell polarity proteins promote macropinocytosis in response to metabolic stress.

Applications

Unspecified application

Species

Unspecified reactive species

Guillem Lambies,Szu-Wei Lee,Karen Duong-Polk,Pedro Aza-Blanc,Swetha Maganti,Cheska M Galapate,Anagha Deshpande,Aniruddha J Deshpande,David A Scott,David W Dawson,Cosimo Commisso

Frontiers in oncology 13:1213715 PubMed38288105

2024

Dual inhibition of atypical PKC signaling and PI3K/Akt signaling dysregulates c-Myc to induce apoptosis in clear cell Renal Cell Carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Khandker Mohammad Khalid,Wishrawana S Ratnayake,Christopher A Apostolatos,Mildred Acevedo-Duncan

Frontiers in oncology 13:1051516 PubMed36776326

2023

14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.

Applications

Unspecified application

Species

Unspecified reactive species

S Breedy,W S Ratnayake,L Lajmi,R Hill,M Acevedo-Duncan

Cellular signalling 77:109819 PubMed33147518

2020

The interruption of atypical PKC signaling and Temozolomide combination therapy against glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Avijit Dey,S M Anisul Islam,Rekha Patel,Mildred Acevedo-Duncan

International journal of oncology 56:1373-1386 PubMed32236625

2020

Simultaneous inhibition of atypical protein kinase‑C and mTOR impedes bladder cancer cell progression.

Applications

Unspecified application

Species

Unspecified reactive species

Rekha Patel,Sm Anisul Islam,Raja Reddy Bommareddy,Tracess Smalley,Mildred Acevedo-Duncan

Protoplasma 257:1149-1163 PubMed32180008

2020

Towards understanding leydigioma: do G protein-coupled estrogen receptor and peroxisome proliferator-activated receptor regulate lipid metabolism and steroidogenesis in Leydig cell tumors?

Applications

Unspecified application

Species

Unspecified reactive species

M Kotula-Balak,E Gorowska-Wojtowicz,A Milon,P Pawlicki,W Tworzydlo,B J Płachno,I Krakowska,A Hejmej,J K Wolski,B Bilinska

Translational lung cancer research 8:667-673 PubMed31737502

2019

Targeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Masaoki Ito,Carles Codony-Servat,Niki Karachaliou,Rafael Rosell

BMC cancer 19:804 PubMed31412817

2019

Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kyung-Hee Kim,Chaeuk Chung,Jin-Man Kim,Dahye Lee,Sang Yeon Cho,Tae Hee Lee,Hyun Jin Cho,Min-Kyung Yeo

The Journal of neuroscience : the official journal 39:5773-5793 PubMed31101759

2019

Protein Kinase C Lambda Mediates Acid-Sensing Ion Channel 1a-Dependent Cortical Synaptic Plasticity and Pain Hypersensitivity.

Applications

Unspecified application

Species

Unspecified reactive species

Hu-Song Li,Xin-Yu Su,Xing-Lei Song,Xin Qi,Ying Li,Rui-Qi Wang,Oleksandr Maximyuk,Oleg Krishtal,Tingting Wang,Houqin Fang,Lujian Liao,Hong Cao,Yu-Qiu Zhang,Michael X Zhu,Ming-Gang Liu,Tian-Le Xu

Cell adhesion & migration 13:106-120 PubMed30417717

2018

The modulation of actin dynamics via atypical Protein Kinase-C activated Cofilin regulates metastasis of colorectal cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

S M Anisul Islam,Rekha Patel,Raja Reddy Bommareddy,Khandker Mohammad Khalid,Mildred Acevedo-Duncan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com